How we made the decision
We check our guidelines regularly to ensure they remain up to date. We based the decision on surveillance 4 years after the publication of hyperglycaemia in acute coronary syndromes: management (2011) NICE guideline CG130.
For details of the process and update decisions that are available, see ensuring that published guidelines are current and accurate in 'Developing NICE guidelines: the manual'.
Previous surveillance update decisions for the guideline are on our website.
We found 9 new studies in a search for randomised controlled trials and systematic reviews published between 18 September 2012 and 11 February 2016.
Evidence identified in previous surveillance 2 years after publication of the guideline was also considered. This included 3 studies identified by search on the 2-year surveillance decision.
From all sources, 12 studies were considered to be relevant to the guideline.
We also checked for relevant ongoing research, which will be evaluated again at the next surveillance review of the guideline.
See appendix A: summary of new evidence from surveillance and references for all new evidence considered.
We considered the views of topic experts, including those who helped to develop the guideline.
Stakeholders commented on the decision not to update the guideline and to transfer the guideline to the static list. Comments received from stakeholders at consultation supported the decision not to update the guideline and to transfer the guideline to the static list. See appendix B for stakeholders' comments and our responses.
See ensuring that published guidelines are current and accurate in 'Developing NICE guidelines: the manual' for more details on our consultation processes.
This page was last updated: 08 July 2016